Skip to main content
. 2016 Jan 29;11(3):2001–2008. doi: 10.3892/ol.2016.4161

Figure 3.

Figure 3.

Coexpression of miR-30c and BCL9 predicts BCR. Kaplan-Meier curves for the BCR-free survival of PCa patients according to (A) BCL9 and (B) miR-30c expression status, and (C and D) combined expression status of BCL9 and miR-30c (other groups: miR-30c-positive/BCL9-negative; miR-30c-positive/BCL9-positive; miR-30c-negative/BCL9-negative). miR, microRNA; BCL9, B-cell lymphoma 9; BCR, biochemical recurrence.